Nutex Health Approved for Dual-Listing on New Nasdaq Texas Exchange

Key Facts

1Nutex Health has received approval for the dual-listing of its shares on Nasdaq Texas.

In a move reflecting the expansion of regional trading venues within the United States, Nutex Health has received formal approval for the dual-listing of its common stock on the Nasdaq Texas exchange. According to reports, trading on this new venue is scheduled to commence at the market open on or about September 23, 2026. This transition represents a corporate expansion of the company's trading venues following regulatory approval for the regional exchange's operations.

This strategic move comes as mid-cap and micro-cap companies seek to improve liquidity and market visibility. Per market data, Nutex Health (NUTX) shares finished at $208.82 (close September 22, 2026), having reached a day high of $212.1. In related market activity, shares of the exchange operator Nasdaq (NDAQ) closed at $94.5 on the same date.

Traders are currently monitoring NUTX price levels following its recent trading range between $201.92 and $212.1 (close September 22, 2026). As trading begins on the new platform, investors are watching for the impact of increased trading venues on liquidity volumes. Additionally, the upcoming economic calendar features U.S. Initial Jobless Claims on September 17, which may influence broader market sentiment for healthcare and mid-cap equities.